Aimed Bio Cash Flow Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Net Income	-22,751	-3,304	-9,023	-6,168
Depreciation & Amortization	1,405	1,464	1,058	780.45
Loss (Gain) From Sale of Assets	-	-0.66	7.24	12.95
Loss (Gain) From Sale of Investments	420	-96.75	1,084	716.25
Stock-Based Compensation	1,143	667.74	1,061	1,015
Other Operating Activities	26,677	3,753	1,518	-87.96
Change in Accounts Receivable	-6,922	-6,922	45.46	-38.64
Change in Unearned Revenue	-469.73	-499.72	1,154	140.79
Change in Other Net Operating Assets	1,113	64.83	450.07	-278.35
Operating Cash Flow	615.55	-4,874	-2,644	-3,908
Capital Expenditures	-280.3	-223.73	-795.7	-451.6
Sale of Property, Plant & Equipment	-	23.14	-	0.63
Cash Acquisitions	-	-	-	-0.04
Sale (Purchase) of Intangibles	-1,456	-1,456	-	-69.8
Investment in Securities	-41,763	-14,412	-13,472	5,888
Other Investing Activities	118.74	-319.85	-232.63	-276.82
Investing Cash Flow	-43,381	-16,389	-14,500	5,090
Long-Term Debt Repaid	-	-475.11	-454.13	-257.1
Net Debt Issued (Repaid)	-523.82	-475.11	-454.13	-257.1
Issuance of Common Stock	8,193	-	5,220	161.66
Other Financing Activities	-0	-	76.8	71.83
Financing Cash Flow	51,348	24,270	15,734	-23.61
Foreign Exchange Rate Adjustments	23.51	18.76	0.61	5.23
Miscellaneous Cash Flow Adjustments	-	-	0	-
Net Cash Flow	8,607	3,026	-1,410	1,163
Free Cash Flow	335.25	-5,098	-3,440	-4,360
Free Cash Flow Margin	1.62%	-43.35%	-2009.11%	-3924.65%
Free Cash Flow Per Share	8.30	-143.71	-100.72	-130.42
Cash Interest Paid	45.21	87.55	118.44	122.89
Cash Income Tax Paid	69.32	130.5	-5.47	13.28
Levered Free Cash Flow	-	-2,704	-520.51	-
Unlevered Free Cash Flow	-	-2,646	-446.09	-
Change in Working Capital	-6,279	-7,357	1,650	-176.2

Source: S&P Global Market Intelligence. Standard template. Financial Sources.